Sibutramine Current Events | Sibutramine News
|
|
|
Sort By:
Page Views | Date |
OBESITY DRUG COULD SUSTAIN WEIGHT LOSS (p 2119)
Results of a clinical trial published in this week's issue of THE LANCET suggest that the drug sibutramine is effective in sustaining weight loss in obese patients. However, questions remain about the drug's long-term safety. Sibutramine is a tertiary amine, originally developed as a potential antidepressant. It has been shown to induce... view more... (2000-12-21)
Chinese slimming capsules
Taking herbal food supplements is certainly not free of risk. view more (2009-04-09)
Dieting and medication may reduce blood pressure in patients with hypertension
Adults with hypertension may be able to lower their weight and their blood pressure by following a weight-loss diet or using the medication orlistat. view more (2008-03-25)
Genes influence effectiveness of weight-loss drug
Obese patients with a specific genetic make-up lose more weight when taking the weight loss drug sibutramine and undergoing behavioral therapy compared to those without this genetic make-up, reports a new study in Gastroenterology, the official journal of the American Gastroenterological Association (AGA) Institute. view more (2008-10-02)
Medication plus behavior changes helps obese adolescents lose weight
The weight loss medication sibutramine, when combined with behavior therapy, allowed hundreds of very obese adolescents to lose an average of 14 pounds over a year. view more (2006-07-18)
New target for obesity and related metabolic disorders
A new study reveals an attractive new target for therapies aimed at the treatment of obesity and related metabolic disorders, researchers report in the March Cell Metabolism. view more (2006-03-08)
Proposed changes to obesity guidelines may harm children in the US
New guidelines on obesity in the U.S. may end up harming children, says an article in this week's BMJ. And an accompanying article goes on to question the financial links between the organisation promoting these proposals and the pharmaceutical industry. view more (2006-06-16)
New clues to how major weight-loss drugs work
Some of the most important weight-loss drugs work by enhancing the effect of the brain chemical serotonin. These include sibutramine (trade name Meridia) and fenfluramine, which was recalled after the combination with dexfenfluramine, called fen-phen, was linked to potentially fatal heart valve abnormalities. view more (2006-07-20)
Bone mineral content continues to increase in obese adolescents during weight loss
Obese teenagers who succeeded in losing weight in a year-long medically supervised weight control program also saw their bone mineral content increase over that period, say researchers from The Children's Hospital of Philadelphia. The finding was reassuring, because adolescence is a critical period for bone health in later life. view more (2008-02-04)
New promising obesity drug may have huge potential
According to trials, a new obesity drug, Tesofensine, which may be launched on the world market in a few years, can produce weight loss twice that of currently approved obesity drugs. view more (2008-10-23)
|
|
|
|
Sort By:
Page Views | Date |
|
